BETHESDA, Md. (WUSA) --The National Institutes of Health released the following statement after a seventh person died from a deadly germ, untreatable by most antibiotics.
We are deeply saddened by the deaths at the NIH Clinical Center related to Klebsiella pneumoniae carbapenemase (KPC). The health and welfare of patients is NIH's top priority, and the NIH has-and will continue to-take every measure possible to protect patients at the Clinical Center and quell transmission.
KPC is among the most serious of the antibiotic-resistant bacterial infections and a persistent problem in health care facilities across the country. The Clinical Center is taking strong action to keep KPC from spreading further, redoubling its efforts to ensure that all the infection control and isolation strategies recommended by the Centers for Disease Control and Prevention (CDC) are followed stringently, that testing for KPC in our patient population and the hospital's inanimate environment is ongoing, and that hygiene and decontamination protocols are followed by all staff at all times.
It is important to remember that KPC does not pose a threat to the general public, but only infects critically ill or immune-compromised patients.
We are keeping the CDC, and county and state officials informed of KPC infections.
NIH officials say the latest victim is a boy from Minnesota who arrived at the hospital in April after having complications from a bone marrow transplant, The Washington Post reported.
To read more about this story click here.